TR-D431285 - dicarboxidine-hydrochloride-salt | 56455-90-4

Dicarboxidine 2HCI is a reactive chemical that can form hydrogen bonds. It is an active substance in the treatment of autoimmune diseases, such as rheumatoid arthritis and chronic inflammatory bowel disease. Dicarboxidine 2HCI has been shown to be effective in treating these conditions by inhibiting the production of inflammatory cytokines. The drug also inhibits cyclooxygenase-1 and -2 enzymes to suppress the production of prostaglandins, which are involved in inflammation. Dicarboxidine 2HCI is a monoclonal antibody that selectively binds to an antigen on the surface of B cells that have become cancerous or infected with HIV virus, making them harmless. This drug also inhibits protein synthesis by binding to polysacharides and polysaccharide receptors on the surface of cells. Dicarboxidine 2HCI has a detectable concentration in humans and has been shown to have anti-inflammatory effects.